UniTTEC Co., Ltd. (000925.SZ) won the bid for the domestication transformation project of the CBTC signal system for Line 1 of the Shenyang Metro from 2024 to 2027.
Zhonghe Technology (000925.SZ) announcement, the company recently received a tender notice from Shenyang Metro Group Co., Ltd. (tender unit)...
Announcement from UniTTEC Co., Ltd. (000925.SZ): The company recently received a "Bid Winning Notice" from Shenyang Metro Group Co., Ltd. (the bidding entity), confirming that the company won the bid for the "Localization Transformation Project of CBTC Signal System for Shenyang Metro Line 1 from 2024 to 2027", with a contract value of approximately 238 million RMB.
The project involves the localization transformation of the signal system for the first phase and extension line of Shenyang Line 1, including the mainline interlocking subsystem (including calculation axis), mainline ATP/ATO subsystem (area controller, data storage unit), onboard subsystem, mainline centralized detection system, training center, design, design coordination, system software development, manufacturing, factory inspection, packaging, transportation, warehousing, installation, installation supervision, testing, experiments, system integration, comprehensive commissioning, safety assessment, acceptance, trial operation, opening, personnel training, provision of spare parts, instruments and tools, correction and maintenance of system defects during the quality assurance period, and other related contents.
Related Articles

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.

Subsidiary company of Shenzhen Nanshan Power (000037.SZ) plans to invest in the construction of a 300MW/600MWh independent energy storage power station in the Cuiheng New Area of Zhongshan City (Phases Two and Three) project.

There is currently disagreement within OpenAI about when to IPO: Altman hopes for the fourth quarter, but the CFO believes they are not yet ready.
Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.

Subsidiary company of Shenzhen Nanshan Power (000037.SZ) plans to invest in the construction of a 300MW/600MWh independent energy storage power station in the Cuiheng New Area of Zhongshan City (Phases Two and Three) project.

There is currently disagreement within OpenAI about when to IPO: Altman hopes for the fourth quarter, but the CFO believes they are not yet ready.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


